No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients

Acta Orthopaedica Scandinavica

Volumn 71, Issue 2, 2000, Pages 129-134

  Neal, B C ^a   Rodgers, A ^a   Gray, H ^a   Clark, T ^a   Beaumont, D D ^a   House, T ^a   Douglas, J E ^a   Reid, I R ^a   MacMahon, S W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ADULT; AGED; ARTICLE; BONE RADIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HETEROTOPIC OSSIFICATION; HIP DISEASE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISABILITY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TOTAL HIP PROSTHESIS;

EID: 0033854397     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/000164700317413085     Document Type: Article

References (12)

1. Towards universal prophylaxis of heterotopic ossification after total hip arthroplasty
2. Ectopic ossification following total hip replacement
3. A coefficient of agreement for nominal scales
4. Maximum likelihood estimation from incomplete data via the EM algorithm
5. Clinical and radiographic evaluation of total hip replacement. A standard system of terminology for reporting results
6. Prevention of heterotopic ossification after total hip replacement: A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation
7. Antiplatelet therapy for the prevention of thrombotic complications after hip fracture
8. A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery
9. Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: Implications for the design and interpretation of thromboprophylaxis trials
10. Trends and patterns in adverse drug reactions to non-steroidal anti-inflammatory drugs reported in Sweden